V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10355267 | 10068918 | 1.81 | 87.6 | null | 2020-03-31 | 2020-07-01 | Cabazitaxel | 02 | null | CABAZITAXEL | 101637425 |
| 10355560 | 10068919 | 1.84 | null | null | null | 2022-03-07 | Azacitidine | 02 | null | AZACITIDINE | 101498072 |
| 10356446 | 10068920 | 1.73 | 57.4 | null | 2021-09-20 | 2021-09-22 | Vinorelbine (oral) | 02 | null | ACALABRUTINIB | 101175884 |
| 10358907 | 10068922 | 1.72 | null | Adjuvant (A) | 2020-12-28 | 2021-01-25 | Cetuximab + FLUOROURACIL + FOLINIC ACID + IRINOTECAN | 02 | N | FLUOROURACIL | 100331139 |
| 10359193 | 10068923 | 1.68 | 60.6 | Adjuvant (A) | 2020-09-12 | 2022-02-18 | Fluorouricil + Folonic Acid (MdG) | 02 | N | BORTEZOMIB + THALIDOMIDE | 100567201 |
| 10359341 | 10068924 | 1.85 | 67 | Palliative (P) | 2022-03-03 | 2022-03-25 | Chlorambucil | 02 | N | CHLORAMBUCIL | 101705819 |
| 10361328 | 10068925 | 1.72 | 70.7 | null | 2022-04-30 | 2022-05-23 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100029162 |
| 10363855 | 10068926 | 1.76 | 67.5 | 03 | null | 2022-03-21 | FLUOROURACIL | 02 | N | VINORELBINE | 101583433 |
| 10364764 | 10068928 | 1.74 | 75 | Palliative (P) | 2018-06-18 | 2018-09-17 | Acalabrutinib | 02 | N | NIRAPARIB | 101416604 |
| 10365670 | 10068932 | 1.75 | 73 | null | 2021-11-06 | 2021-11-16 | Vinorelbine (oral) | 02 | null | FLUOROURACIL | 101222193 |
| 10367063 | 10068934 | 1.67 | 91.75 | null | 2021-05-30 | 2021-05-31 | BORTEZOMIB + THALIDOMIDE | 02 | null | VINORELBINE | 100261662 |
| 10367828 | 10068938 | 1.71 | 68.9 | Adjuvant (A) | 2020-01-08 | 2020-04-01 | BORTEZOMIB + THALIDOMIDE | 02 | N | DABRAFENIB | 101414832 |
| 10367882 | 10068939 | 1.87 | 67.3 | Palliative (P) | 2020-07-12 | 2020-07-19 | Trifluridine + Tipiracil | 02 | N | TIPIRACIL + TRIFLURIDINE | 100594389 |
| 10368044 | 10068940 | 1.68 | 90 | null | 2019-11-17 | 2020-03-09 | CVD | 02 | null | BORTEZOMIB + CYCLOPHOSPHAMIDE | 100186007 |
| 10368801 | 10068942 | 1.66 | 70.3 | Palliative (P) | 2019-05-17 | 2019-06-01 | Chlorambucil | 02 | N | CHLORAMBUCIL | 101799038 |
| 10369028 | 10068943 | 1.7 | 59.3 | 03 | 2020-09-22 | 2020-09-22 | Azacitidine | 02 | null | AZACITIDINE | 100358720 |
| 10369153 | 10068944 | null | null | Curative (C) | null | 2018-05-03 | CISPLATIN + VINORELBINE | 02 | N | CISPLATIN | 100332133 |
| 10369157 | 10068945 | 1.75 | 79.3 | null | 2019-09-14 | 2019-10-04 | Bortezomib + Cyclophos + Dex | 02 | null | BORTEZOMIB + CYCLOPHOSPHAMIDE | 100429026 |
| 10369910 | 10068948 | 1.62 | 110.9 | Palliative (P) | 2015-12-16 | 2017-03-01 | Palbociclib | 02 | N | PALBOCICLIB | 101524358 |
| 10370151 | 10068949 | 1.75 | 75.4 | null | 2018-09-17 | 2018-10-13 | Capecitabine (14 day) + Irinotecan | 02 | null | CABOZANTINIB | 100082446 |
| 10370515 | 10068950 | 1.66 | 70 | Curative (C) | 2019-05-31 | 2019-06-01 | Bortezomib + Cyclophos + Dex | 02 | N | BORTEZOMIB + CYCLOPHOSPHAMIDE | 101859752 |
| 10370593 | 10068951 | 1.76 | 102.8 | Curative (C) | 2019-05-29 | 2019-05-29 | Melphalan IV High dose | 02 | null | MELPHALAN | 101250125 |
| 10370826 | 10068952 | 1.68 | 68 | 03 | 2021-01-13 | 2022-05-11 | GEMCITABINE | 02 | N | GEMCITABINE | 100415103 |
| 10371607 | 10068953 | 1.54 | 88.8 | null | 2019-08-11 | 2019-08-12 | DABRAFENIB | 02 | null | NIRAPARIB | 100704184 |
| 10371951 | 10068956 | null | 62 | null | 2020-01-23 | 2020-02-23 | DABRAFENIB | 02 | null | ACALABRUTINIB | 100237364 |
| 10372545 | 10068957 | 1.69 | 74.9 | Neo-adjuvant (N) | 2019-02-21 | 2019-03-26 | Trifluridine + Tipiracil | 02 | N | TIPIRACIL + TRIFLURIDINE | 101674853 |
| 10372614 | 10068959 | null | 61.1 | Adjuvant (A) | 2016-08-22 | 2016-09-14 | GEMCITABINE | 02 | N | GEMCITABINE | 100242286 |
| 10372696 | 10068960 | 1.5 | 41.5 | 03 | 2019-02-10 | 2019-02-28 | Azacitidine | 02 | N | AZACITIDINE | 100609012 |
| 10373066 | 10068961 | 1.7 | 118 | 03 | 2020-06-02 | 2020-06-22 | Doce + Pertuzumab + Trastuz IV Load | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100977109 |
| 10373503 | 10068962 | null | 71.2 | Curative (C) | 2018-08-31 | 2019-11-18 | DABRAFENIB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100235713 |
| 10373551 | 10068963 | 1.68 | 70 | 03 | null | 2019-07-20 | CISPLATIN + VINORELBINE + RT | 02 | N | FLUOROURACIL | 100660407 |
| 10373856 | 10068964 | 1.66 | 0 | Palliative (P) | 2019-06-05 | 2019-06-08 | Niraparib | 02 | N | CABOZANTINIB | 100381016 |
| 10373928 | 10068966 | 1.69 | 76.6 | null | 2022-02-10 | 2022-02-10 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | null | CHLORAMBUCIL + OBINUTUZUMAB | 100786051 |
| 10374243 | 10068968 | 1.56 | 40.3 | Palliative (P) | 2019-12-16 | 2019-12-25 | Chlorambucil | 02 | N | CHLORAMBUCIL | 100520147 |
| 10374740 | 10068970 | 1.74 | null | Palliative (P) | 2010-12-21 | 2014-08-29 | Carboplatin + Liposomal Doxorubicin | 02 | N | NIRAPARIB | 101676836 |
| 10374886 | 10068971 | 1.77 | 71.6 | null | 2021-03-30 | 2021-03-30 | DABRAFENIB | 02 | null | BORTEZOMIB + THALIDOMIDE | 101053096 |
| 10374899 | 10068972 | 1.55 | 0 | null | 2021-12-14 | 2022-03-19 | null | 02 | null | NIRAPARIB | 101121401 |
| 10374966 | 10068973 | 1.7 | 57.7 | Palliative (P) | 2020-03-05 | 2020-03-05 | GEMCITABINE | 02 | null | GEMCITABINE | 101219231 |
| 10375040 | 10068974 | 1.88 | 76.8 | null | 2021-02-22 | 2021-04-08 | VINORELBINE | 02 | null | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 100184254 |
| 10375153 | 10068975 | 1.83 | 75 | 03 | 2020-08-06 | 2020-08-06 | Palbociclib | 02 | N | PALBOCICLIB | 101125657 |
| 10376078 | 10068978 | 1.82 | 88.6 | 03 | 2020-08-13 | 2020-09-03 | Carboplatin + Liposomal Doxorubicin | 02 | N | NIRAPARIB | 100393346 |
| 10376546 | 10068979 | 1.88 | 82.3 | 03 | 2018-08-07 | 2018-08-07 | DABRAFENIB | 02 | N | CISPLATIN + VINORELBINE | 101359054 |
| 10378252 | 10068982 | 1.8 | 0 | Neo-adjuvant (N) | 2019-11-01 | 2019-11-01 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101203567 |
| 10378276 | 10068983 | 1.69 | 57.5 | Palliative (P) | 2020-10-16 | 2020-10-19 | Bortezomib + Panobinostat | 02 | N | BORTEZOMIB + PANOBINOSTAT | 100452186 |
| 10379044 | 10068988 | 1.67 | 48 | null | 2020-01-12 | 2020-08-28 | BORTEZOMIB + THALIDOMIDE | 02 | null | DABRAFENIB | 100876909 |
| 10379136 | 10068989 | null | 59.4 | Palliative (P) | 2018-10-22 | 2019-01-31 | Azacitidine | 02 | N | AZACITIDINE | 101684977 |
| 10379346 | 10068990 | 1.8 | 72.4 | null | 2018-09-11 | 2018-09-12 | DABRAFENIB + TRAMETINIB | 02 | null | DABRAFENIB + TRAMETINIB | 101822681 |
| 10379717 | 10068994 | 1.8 | 106.4 | Palliative (P) | 2018-06-20 | 2018-06-22 | GEMCITABINE | 02 | N | CAPECITABINE + IRINOTECAN | 100925496 |
| 10379774 | 10068996 | 0 | 78.5 | 03 | 2019-05-17 | 2019-08-05 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | N | BORTEZOMIB + CYCLOPHOSPHAMIDE | 101333127 |
| 10380023 | 10068997 | 1.64 | 73.1 | Curative (C) | 2022-04-21 | 2022-04-21 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | CHLORAMBUCIL + OBINUTUZUMAB | 100643928 |